openPR Logo
Press release

Key Bioabsorbable Stents Market Trend for 2025-2034: MicroPort Scientific Corporation Launches World's First Next-Generation Fully Bioresorbable Cardiac Stent, Firesorb, with Market Approval in China

03-21-2025 10:19 AM CET | Health & Medicine

Press release from: The Business Research Company

Bioabsorbable Stents Market Size

Bioabsorbable Stents Market Size

What Is the Future Outlook for the Bioabsorbable Stents Market's Size and Growth Rate?
In recent times, there has been a robust growth in the bioabsorbable stents market size. The market value is expected to increase from $0.37 billion in 2024 to approximately $0.41 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.9%. The historical growth can be credited to the growing incidence of cardiovascular diseases, augmented demand for minimally invasive procedures, higher awareness related to bioabsorbable stents, an increase in disposable incomes, and substantial industry investments.

The market for bioabsorbable stents is expected to experience substantial growth in the upcoming years, with forecasts predicting a value of $0.59 billion in 2029 at a compound annual growth rate of 9.8%. The predicted rise in the projected period can be ascribed to broader clinical indications, customisation and personalisation, worldwide expansion, and patient-friendly choices. Influential trends in the expected timeframe encompass advancements in bioabsorbable materials, clinical advancements, clinical data and research, hybrid stent designs, extended absorption periods, as well as collaborations and partnerships.

What Is Stimulating Growth in the Bioabsorbable Stents Market?
The bioabsorbable stents market is likely to witness significant growth due to the rising incidence of heart failure. This disorder is defined by the heart muscle's diminished capacity to pump blood efficiently, which leads to a surplus of fluid in the body. Bioabsorbable stents can play a pivotal role in managing heart failure, improving heart function and lessening its symptoms. For instance, as per the Heart and Stroke Foundation of Canada, a reputable Canada-based institution for information on stroke, heart diseases, surgeries, and treatments, as of February 2022, there are 750,000 individuals suffering from heart failure. There is also an annual increase of 100,000 new cases of this uncurable condition. It is predicted that by 2030, the healthcare expenses related to heart failure in Canada could escalate to $2.8 billion annually. Consequently, the escalating rate of heart failure is anticipated to fuel the growth of the bioabsorbable stents market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

Which Key Market Leaders Are Driving Bioabsorbable Stents Industry Growth?
Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation

What Are the Emerging Trends in the Bioabsorbable Stents Industry?
Significant players in the bioabsorbable stents market are prioritizing the development of novel technologies such as the latest iteration of Bioresorbable Cardiac Stent, to boost their market profitability. This latest generation refers to state-of-the-art medical devices intended for use in treating coronary artery disease. They are crafted from materials that biodegrade after performing their duty of maintaining the artery unblocked. In July 2024, MicroPort Scientific Corporation, a leading medical device manufacturer based in China, obtained the approval of the world's first next-generation fully bioresorbable cardiac stent from the National Medical Products Administration (NMPA) in China. Firesorb, the product developed by MicroPort Scientific Corporation, is envisioned to dissolve entirely within three years, thereby considerably minimizing long-term issues like thrombosis. Clinical experiments including 1,468 subjects showcased promising outcomes, such as a minimal thrombosis rate of 0.32% and a target lesion failure rate over four years of a mere 4.3%. Its innovative design of thin struts and better endothelial coverage compared to previous stents have earned accolades from top medical professionals.

What Are the Main Segments in the Bioabsorbable Stents Market?
The bioabsorbable stents market covered in this report is segmented -

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents
2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents
3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:
1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents
2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Geographic Area Leads the Bioabsorbable Stents Market?
North America was the largest region in the bioabsorbable stents market in 2023. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Is Covered In The Bioabsorbable Stents Global Market Report?

- Market Size Analysis: Analyze the Bioabsorbable Stents Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Bioabsorbable Stents Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Bioabsorbable Stents Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Bioabsorbable Stents Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3269

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Bioabsorbable Stents Market Trend for 2025-2034: MicroPort Scientific Corporation Launches World's First Next-Generation Fully Bioresorbable Cardiac Stent, Firesorb, with Market Approval in China here

News-ID: 3929424 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients